Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.

$1,637,478ZIAFY2020HLNIH

National Heart, Lung, And Blood Institute

Investigators

Christopher Hourigancontact

Linked publications, trials & patents

Paper 39506075 Paper 39455897 Paper 39424958 Paper 37607457 Paper 37534515 Paper 37524919 Paper 37432432 Paper 37406882 Paper 37353292 Paper 37180102 Paper 36934059 Paper 36881031 Paper 36758209 Paper 36543879 Paper 36310182 Paper 36260702 Paper 36170795 Paper 36044658 Paper 35868306 Paper 35368040 Paper 35072377 Paper 35017151 Paper 34551064 Paper 34547770 Paper 34258102 Paper 34036237 Paper 33950704 Paper 33784346 Paper 33775615 Paper 33758317 Paper 33755090 Paper 33054127 Paper 33010430 Paper 32761235 Paper 32190831 Paper 32162718 Paper 32062672 Paper 31985806 Paper 31860405 Paper 31804716 Paper 31666655 Paper 31539534 Paper 31245276 Paper 31064876 Paper 30936058 Paper 30842218 Paper 30697529 Paper 30578959 Paper 30552400 Paper 30523342 Paper 30518681 Paper 30500073 Paper 30333627 Paper 30189044 Paper 30171026 Paper 30026009 Paper 29713444 Paper 29330221 Paper 29027628 Paper 28947565 Paper 28925935 Paper 28882835 Paper 28794968 Paper 28693586 Paper 28644756 Paper 28537498 Paper 28386105 Paper 28264642 Paper 28190619 Paper 28126965 Paper 27959750 Paper 27698101 Paper 27544285 Paper 27185839 Paper 26568255 Paper 26514194 Paper 26354756 Paper 26190358 Paper 26111465 Paper 26111461 Paper 25985051 Paper 25932335 Paper 25706110 Paper 25665046 Paper 25387087 Paper 25016196 Paper 25003026 Paper 24831837 Paper 24485019 Paper 24472813 Paper 24327695 Paper 24291784 Paper 24241580 Paper 24188917 Paper 24141092 Paper 24013666 Paper 23799371 Paper 23445368

View original record on NIH RePORTER →